The Quest for Optimal Therapy: Sofosbuvir and Ribavirin in Chronic Hepatitis C - A Systematic Review

Authors

  • Monica Devi Yerramsetti
  • Olawale O Olanisa
  • Payal Jain
  • Qasim S Khan
  • Abhijith C Vemulapalli
  • Abanob A Elias
  • Samia Rauf Butt

DOI:

https://doi.org/10.56570/jimgs.v2i2.126

Keywords:

Sofosbuvir, Ribavirin, Chronic Hepatitis-C, Cirrhosis, Safety, Efficacy

Abstract

Chronic Hepatitis C (CHC) infection leads to liver
cirrhosis, liver failure and hepatocellular carcinoma. It
is mostly treated with Sofosbuvir and ribavirin or in
combination with other Direct-acting antivirals (DAAs)

Downloads

Published

2023-09-19

Issue

Vol. 2 No. 2 (2023): Vol. 2 No. 2 (2023)

Section

Articles

How to Cite

1.
Monica Devi Yerramsetti, Olawale O Olanisa, Payal Jain, et al. The Quest for Optimal Therapy: Sofosbuvir and Ribavirin in Chronic Hepatitis C - A Systematic Review. Journal For International Medical Graduates . 2023;2(2). doi:10.56570/jimgs.v2i2.126